Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05777278
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2023-02-21
Brief Title:
Savolitinib Plus Docetaxel as 2L in EGFRALKROS1MET ex14m-wildtype NSCLC With MET Overexpression
Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Organization:
The First Affiliated Hospital of Guangzhou Medical University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-21
First Submit QC Date:
March 17 2023
Study First Post Date:
2023-03-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-09
Last Update Post Date:
2023-10-10
Last Update Post Date Type:
ACTUAL